Company Overview
American HealthCare Capital is exclusively representing a licensed New Jersey behavioral health platform delivering substance use disorder (SUD) medical detox, SUD residential treatment, and mental health outpatient services across Central New Jersey. The platform operates from a multi-site footprint including a detox/residential campus, a separately licensed outpatient mental health location, and an additional pre-revenue facility currently in late-stage NJ DOH licensure review.
Strategic Repositioning
The Company is in the middle of a deliberate strategic repositioning: a 40-bed detox and residential expansion is undergoing build-out, while the historically marketed SUD outpatient program is being wound down to strengthen referral relationships with New Jersey outpatient providers that previously bypassed the platform. The mental health outpatient program is active, in good standing, and continues to grow.
Financial Overview
The Company generated revenue of $12.8 million in 2024, with adjusted EBITDA of approximately $2.0 million, representing a 15.7% margin. In 2025, revenue increased to $13.5 million, while adjusted EBITDA grew to approximately $2.9 million, representing a 21.6% margin. For the year-to-date period from January through April 2026, the Company generated revenue of $4.68 million and adjusted EBITDA of approximately $1.20 million, representing a 25.6% margin. This annualizes to approximately $14.1 million of revenue and $3.6 million of adjusted EBITDA.
Reported EBITDA is adjusted for a defined set of one-time and transitional items including non-recurring maintenance, project-based licensing consulting, labor-relations legal fees capped at the applicable insurance deductible, pre-revenue lease expense on an unlicensed facility, and a scheduled vendor settlement.
Exit Plan
Ownership is seeking the right strategic or capital partner to scale the platform through the bed expansion, the new licensure ramp, and the broader operational repositioning. Ownership is open to remaining involved during a transition period of mutually agreed length.
Asking Price
The Company is willing to accept offers/